Clinical Trials of Niclosamide, Repurposed Drug For COVID-19 Treatment, Initiated by CSIR India & Laxai Life Sciences

Clinical Trials of Niclosamide, Repurposed Drug For COVID-19 Treatment, Initiated by CSIR India & Laxai Life Sciences: 

CSIR India & Laxai Life Sciences initiate clinical trials of repurposed drug Niclosamide for #COVID19 treatment. The trial is multi-centric, phase-II, randomized, open label clinical study to evaluate efficacy, safety & tolerability of the drug: Ministry of Science & Technology pic.twitter.com/nXJo3dqXoG

— ANI (@ANI) June 6, 2021

Niclosamide has been extensively used in past for treatment of tapeworm infection in adults & children. Its safety profile has been tested over time & has been found safe for human consumption at different dose levels: Ministry of Science & Technology

— ANI (@ANI) June 6, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)